Monthly Archives: December 2024

Update 03/07/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Estradot® 50micrograms/24hours patches (SSP079) and Estradot® 25micrograms/24hours patches (SSP082). Both SSPs were due to expire on 4 July 2025. The end date for all two Estradot® SSPs has been further extended to Friday [...]

The post SSPs for Estradot® patches (SSP079 and SSP082) extended appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Prednisolone 20mg/100ml rectal solution MSN/2024/116 Tier 2 – medium impact Date of issue: 19th December 2024 Prednisolone 20mg/100ml rectal solution is out of stock until February 2025. Alternative rectal steroids remain available and can support an increased demand. A copy of [...]

The post Medicine Supply Notification: Prednisolone 20mg/100ml rectal solution appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release) MSN/2024/114 Tier 2 – medium impact Date of issue: 19th December 2024 Isosorbide mononitrate 10mg and 20mg immediate-release (IR) tablets are in limited supply until late February 2025. Isosorbide mononitrate 40mg IR tablets [...]

The post Medicine Supply Notification: Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release) appeared first on Community Pharmacy England.

The Health Secretary Wes Streeting MP appeared before the Health and Social Care Select Committee in Parliament yesterday (December 18th) to answer questions related to his brief.   In response to questions – including from All-Party Parliamentary Group on Pharmacy Member Gregory Stafford MP – the Secretary of State said he wanted to: “reassure pharmacies across [...]

The post Health Secretary pledges to take ‘enormous’ pharmacy pressures into account appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) Drug alert number: EL (24)A/63 Date issued: 19 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Vyvgart 1000 mg solution for injection (Argenx BV) DMRC reference number: DMRC-34131563 Company name:Argenx [...]

The post MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) appeared first on Community Pharmacy England.